1. Introducing Vantas: The First Once-Yearly Luteinising Hormone-Releasing Hormone Agonist 
Neal Shore 
European Urology Supplements 
Volume 9, Issue 8, Pages (October 2010)
DOI: /j.eursup
Copyright © 2010 European Association of Urology Terms and Conditions

2. Fig. 1
Two-dimensional structures of histrelin, goserelin and leuprolide.
European Urology Supplements 2010 9, DOI: ( /j.eursup )
Copyright © 2010 European Association of Urology Terms and Conditions

3. Fig. 2
Three-dimensional structures of histrelin, goserelin and leuprolide.
European Urology Supplements 2010 9, DOI: ( /j.eursup )
Copyright © 2010 European Association of Urology Terms and Conditions

4. Fig. 3 Pivotal phase 3 study design [3].
European Urology Supplements 2010 9, DOI: ( /j.eursup )
Copyright © 2010 European Association of Urology Terms and Conditions

5. Fig. 4
Effect of the histrelin implant on median serum testosterone levels in patients with advanced prostate cancer [3].
European Urology Supplements 2010 9, DOI: ( /j.eursup )
Copyright © 2010 European Association of Urology Terms and Conditions